FIELD: medicine. SUBSTANCE: method involves determining acid and alkaline phosphotases and their proportion in patient peripheral blood neutrophiles before and in the course of treatment. The latter one being increased when compared to the initial one, the treatment is predicted to be efficient. Reduction or no changes in the relation binding the values being observed, therapy correction is predicted to be necessary. EFFECT: enhanced effectiveness of patient treatment control. 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF DETERMINATION OF ANTITUMORIGENIC THERAPY EFFECTIVENESS | 1991 |
|
RU2021620C1 |
| METHOD OF CONTROL OF EFFICIENCY OF ANTITUMOR TREATMENT OF WOMEN WITH MALIGNANT GENITALIA TUMORS | 1999 |
|
RU2170433C2 |
| METHOD FOR DIAGNOSTICS OF CANCER RELAPSES AND METASTASES | 1993 |
|
RU2082984C1 |
| METHOD FOR PREDICTING COMPLICATIONS OCCURRENCE IN PERFORMING ANTITUMOR TREATMENT | 1995 |
|
RU2107918C1 |
| METHOD FOR PREPARING UTERINE NECK CARCINOMA PATIENTS OF THE III STAGE FOR MAKING OPERATION | 1996 |
|
RU2149661C1 |
| METHOD FOR APPLYING PROLONGED PHARMACOTHERAPY | 2003 |
|
RU2271833C2 |
| METHOD FOR DIAGNOSING PRIMARY FOCUS OF MALIGNANT TUMOR | 1998 |
|
RU2146057C1 |
| METHOD FOR TREATMENT OF UTERUS CERVIX CANCER | 2004 |
|
RU2261706C1 |
| METHOD FOR ESTIMATING ANTITUMOR THERAPY EFFECTIVENESS IN TREATING PATIENTS FOR OVARIAN CARCINOMA | 2005 |
|
RU2293329C2 |
| METHOD FOR TREATING RELAPSES OF UTERINE CERVIX CANCER | 2003 |
|
RU2243766C1 |
